mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.004 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.005 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.005 |
mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.007 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.008 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.008 |